Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Yeah, this is going to get tough! Brilacidin has been through so many trials and is much further along than others.
Great article on WHY this virus becomes lethal. In summary; it’s the bacteria and resistant bacteria
https://apple.news/A4yrwqSUyRT2tL4oh4tsVHw
Even though it is small like 1% chance of B being a Corona hit.....it is a chance and something that could blow this share price into many dollar territory. Fun times
2.5 million volume first 10 minutes
Wholly shit. Is this because of the Oral formulation for IBD?
I have FAITH in that statement. I believe this company is ready to flourish. I bought another 40K today. Let’s see some Coronavirus updates and an OM Deal please
Brilacidin - #1 in list of drugs for Corona
https://www.clinicaltrialsarena.com/analysis/coronavirus-mers-cov-drugs/
I don’t care. The facts are that Fox Chase and others have done pre clinical work on B for viruses and have had success.
So as Leo stated: the benefits of B is that it has been tested for years and years and is in a few phase 3 start gates. The safety is proven.
This is where big money and the world will start to dice through all types of drugs to find something to help.
I say ride this trend with some PR and the more the Health world inquires to Leo. Let the world know!
At the same time continue to drop PRs about ORAL B for IBD and OM so the more eyes on this for Coronavirus they see the value and how undervalued this company is. We get new eyes and new longs to lock up the float
15 million market cap. A BP running and paying for phase 3 with 20 plus million in milestones attached. A possible Oral ready IBD transition into a 20 billion plus market. I mean! I’d say there is only upside here at 15 million market cap
We’ve been in rough waters for the past years. No need to rehash. This very small trial is significant and we are one week away to finding out if the BDD delivery method is viable. We know Brilacidin works. We just need to find out if it can be delivered precisely via oral tablet. There are not a lot of good oral options for Crohns or UC. It’s a huge market and if we can show we can deliver the robust drug to the money spot. Game on! A 230 million share OS company can reach many dollars imo.
Let’s hope for a Friday after market miracle PR.
Please show positive TIMED RELEASE via Oral. 46 billion GI indications need new ORAL treatment options
No no. They partnered with BDD Pharma who used their patented Oralogik technology to formulate a pill to control the erosion to a specific area of the intestine.
The in vitro was positive and now the human trial will show results in the next 30 days imo.
If the results show the technology hit the money spot! And it was safe! Get ready to tap a 48 billion market!
“Researchers will use gamma scintigraphy to evaluate the transit of Brilacidin to the colon. Safety and tolerability are, of course, top priority, but targeted delivery to the intended site is not far behind in importance.”
This should be black and white unlike some of the other data from previous trials. IMO - all of the B data across all indications have a level of positive results and so I do believe the properties of B are valuable. B-OM good results. B-UP enema great results and partnered. B-absssi - great results and not lucrative enough for BP.
So if B can all of a sudden continue to be safe and effective but now in an ORAL form and deliver deep into the GI tract for UC, and Crohn’s.
I believe my long term friends........we have just hit pay dirt.
Well know soon enough.
Crohns market by 2026 will be 13.4 billion. Not small.
Cohort 2 scheduled for Tues dosing
Please ask for Results that include ZERO doubt on this trial! I want to see them and hear no BS in the background. I’ll talk to the man upstairs for this request later
Back LIVE! In the trial conversation! Love cohort updates!
Oral B trial is a possible game changer. Let’s pray this one shows purpose to move forward.
Or .....several dozen strong shareholders have been requesting his resignation this past year. Look at the company value since his arrival. His old school keep quiet and hope for the best attitude killed this company and he brought zero deals with his Rolodex. Good luck Dr B but it’s time to start fresh and start making noise in this get rich millennial world. IMO.
Ipix is at .05-.06. It’s time to climb back up.
B-OM is where can potentially see good value. And I assume ipix hires the locust firm to help get it out there for an acceptable offer. Swish and spit is well worth it. I did enjoy the PR yesterday because it is relevant and Leo undershot many of the projections...so a more recent dive into data is always a bonus
It’s the smallest tool in the shed. It’s the first deals. With the share price as is....we have to accept it. The more important less focused fact, is that it truly is validation to have a billion dollar bio as a partner. Also they shoulder ALL dev costs and trial costs....so we can sit back and accept their data and spin that into our files for other B negotiations. It adds value in that regard. A million upon phase 3 start will be nice. And the data will move the needle for other indications imo.
Found it. Commencement of phase 3. Then another million upon first marketing approval application. 3 million upon approval fda and 1 million for EMA.
Then the remaining 18 million are sales based. 100-200-300 million net sales. Tier 3-6-9 million
Was that one of milestones? Start phase 3 or Complete?
I think the B phase 1 Oral trial that should start soon will start to prop this share price. IMO.
It will only take a couple months and if successful the possibilities of Oral B for IBD will be endless.
Bingo. Ipix has increased approx 20 million shares since April 30th
192 million to 212 million April 30th compared to Nov 8th
Let’s hope Dr B can dig deep and utilize his rolodex to secure a solid deal with financing.
B-OM has enormous potential. IMO.
If they Alfa do not get moving on UPS progress IPIX can take back all rights on the product and pocket the 400K from my understanding.
BOM needs to be the focus and we need to move it fast. IMO.
Nope. I’ve given a rest on buying for several months. It seems like a round by the mofo is going on now. If I close a deal I’ve been working and reap the reward I will try to scoop up more prior to the phase 1 B Oral trial in December. My bets ipix and marketing crew get the excitement rolling into the new year. Might even try to flip for once ;). Lol
My core is untouched but these cheapies could boom soon
Chatter should pick up when we finally launch the B Oral trial. It should bring excitement and new PR......hopefully we do hire a PR firm soon to get that excitement to a higher level. In addition and parallel we should see Alfa starting their trials in UP
Sorry, I’m in California for a new Product launch. I had every intention. I’m looking on this board for updates myself. Sorry again.
Nope. I voted already though. Have you?
So Kevetrin could be next? Great catch and opinion
It will be a lot of the same: going concerns, increase in shares, etc....
We wait for another partnership for OM to move the needle imo.
10-K today ? Or Friday
Another deal is close. IMO. Ear to the ground... OM needs to move.
Did anyone see the Otezla Amgen deal? Wow: 13 billion
I just keep adding. It would have been smart to follow that advice......but........lol, I would have to pay taxes :)
I’m going to meet Leo in Michigan and will decide whether I continue to add - hold - sell based on what I feel then.
205 million is what I expected and more to get thru phase 3. So I hope to see OM deal soon where we get through it
According to the filing Dr M has 18 million less shares than the K in 2018. If he sold, wouldn’t he need to file a form 4?
As of APRIL 30th there were 192,132,420 CLASS A Outstanding Shares and 909,090 CLASS B Outstanding Shares.
As of Aug 8th, there are 205,620,200 CLASS A Outstanding Shares and also 909,090 CLASS B Outstanding Shares.
That is a difference of 72 business days adding 13,487,780 shares to the OS making an average daily increase of 187,330
If you look at the chart in that time frame we climbed quick in early May to almost 45 cents and then dropped back to 13 cents.
bigcharts.marketwatch.com/advchart/frames/frames.asp?show=&insttype=Stock&symb=ipix&time=100&startdate=5%2F1%2F2019&enddate=8%2F08%2F2019&freq=1&compidx=aaaaa%3A0&comptemptext=&comp=none&ma=0&maval=9&uf=0&lf=1&lf2=0&lf3=0&type=2&style=320&size=2&x=45&y=16&timeFrameToggle=false&compareToToggle=false&indicatorsToggle=false&chartStyleToggle=false&state=8
I’ll be there. Look forward to seeing uou